NFE2L2 and thyroid gland carcinoma: By downregulating p62 protein expression, upregulating Keap1 protein expression, reducing Nrf2 nuclear translocation, and inhibiting the expression of Nrf2 downstream antioxidant factors, IDET ultimately increases ROS levels, inhibits thyroid cancer cell proliferation, and enhances taxol sensitivity.